Anxiety, Psoriasis (PsO)
Conditions
Keywords
Surveys and Questionnaires, Acoustic Stimulation, Complementary Therapies
Brief summary
Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.
Interventions
BEHAVIORALMusic Therapy
Participants listen to the iso-principle music with added auditory beat stimulation playlist for 23-30 minutes.
BEHAVIORALPink Noise
Participants listen to the pink noise playlist for 23-30 minutes.
Sponsors
University of California, San Francisco
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥18 years * Self-reported dermatologist-diagnosed psoriasis * GAD 2-Item Score ≥1 at screening * Ability to consent and complete pre- and post-intervention surveys. * Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.
Exclusion criteria
* Severe hearing impairment precluding headphone listening * Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe. * Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety: State Trait Inventory for Cognitive and Somatic Anxiety (STICSA) | From the pre-intervention survey to the post-intervention survey, approximately 30 minutes. | The STICSA has good reliability and validity as a measure of state and trait cognitive and somatic anxiety. In this study, the post-intervention anxiety score is subtracted from the pre-intervention anxiety score, giving a measure of anxiety reduction. Greater anxiety reduction scores would indicate a better anxiety outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mood: Positive and Negative Affect Scale (PANAS) | From the pre-intervention survey to the post-intervention survey, approximately 30 minutes. | The PANAS has demonstrated good reliability and validity, and has been widely used in numerous studies to assess mood. In this study, the post-intervention PANAS scores are subtracted from the pre-intervention PANAS scores, giving a measure of positive and negative mood changes. The scale generates two scores: 1) Positive affect (higher score indicates better mood outcome) and 2) Negative affect (higher score indicates worse mood outcome). |
| Itch: Itch Numeric Rating Score (INRS) | From the pre-intervention survey to the post-intervention survey, approximately 30 minutes. | The INRS has good reliability and validity as a measure of 24-hour itch severity, though validity testing over more acute intervals remains limited. In this study, the post-intervention itch score is subtracted from the pre-intervention itch score, giving a measure of itch reduction. Greater itch reduction scores may indicate a better itch outcome. |
Countries
United States
Contacts
CONTACTAmélie Spangenberg, Psoriasis Clinical Research Fellow, MBBS
PRINCIPAL_INVESTIGATORWilson Liao, MD
University of California, San Francisco
Outcome results
None listed